A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion

INTRODUCTION: Radium 223 (Ra223) given for six cycles has proven efficacy in clinical trials, but its population-level generalizability has not been well-described. The objectives of this study were to describe population-based Ra223 use in the abiraterone and enzalutamide era and identify factors a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Can Urol Assoc J
Autores principales: Parimi, Sunil, Tsang, Erica, Alexander, Abraham, McKenzie, Michael, Bachand, Francois, Sunderland, Katherine, Chi, Kim N., Aparicio, Maria, Worsley, Daniel, Tyldesley, Scott
Formato: Artigo
Lenguaje:Inglês
Publicado: Canadian Medical Association 2017
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5963449/
https://ncbi.nlm.nih.gov/pubmed/29382449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4415
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares